United States

Nate Raymond

Opioid maker Insys paid kickbacks to physician assistant, jury hears

Dec 12 2018

CONCORD, N.H. A former Insys Therapeutics Inc sales representative now married to the drugmaker's ex-CEO said on Wednesday she arranged to have a physician assistant in New Hampshire receive kickbacks to prescribe patients its addictive fentanyl spray.

Pennsylvania hospital system, CEO resolve billing probe for $12.5 mln

Dec 12 2018

A Pennsylvania-based hospital system and its chief executive have agreed to pay $12.5 million to resolve allegations that they engaged in a scheme to artificially inflate reimbursements from federal healthcare programs for orthopedic surgeries.

Edwards owes Boston Scientific $35 mln in heart valve patent case - jury

Dec 12 2018

A federal jury in Delaware has ordered medical device maker Edwards Lifesciences Corp to pay $35 million after finding a heart valve replacement system it makes infringes a patent held by rival Boston Scientific Corp.

Doctor pleads guilty after patient overdoses on Insys-made opioid

Dec 12 2018

A Nevada doctor has pleaded guilty to illegally distributing a fentanyl-based pain spray made by Insys Therapeutics Inc that was meant for cancer patients to a state court judge who did not have the disease and later died of an overdose after using the powerful opioid.

Physician assistant faces U.S. trial over Insys opioid kickbacks

Dec 12 2018

Dec 12 A former physician assistant is set to face trial in New Hampshire on Wednesday over charges he accepted kickbacks from Insys Therapeutics Inc to prescribe a highly addictive fentanyl spray the drugmaker produced.

Target resolves automatic prescription refill probe for $3 million

Dec 11 2018

Target Corp will pay $3 million to resolve claims that it improperly billed Massachusetts' Medicaid program for unauthorized automatic prescription refills, the state's attorney general said on Tuesday.

Olympus unit pleads guilty to resolve U.S. duodenoscope probe

Dec 10 2018

An Olympus Corp subsidiary pleaded guilty on Monday and agreed to pay $85 million to resolve charges that it failed to file reports with U.S. regulators regarding infections connected to its duodenoscopes while continuing to sell the medical devices used to view the gastrointestinal tract.

FTC's authority faces appellate test in Shire ViroPharma case

Dec 10 2018

The U.S. Federal Trade Commission on Tuesday will urge a federal appeals court to overturn the dismissal of its lawsuit accusing a unit of drugmaker Shire PLC of violating antitrust laws, saying the lower court's ruling threatens its enforcement abilities.

J&J must face antitrust lawsuits over Remicade: judge

Dec 10 2018

A federal judge in Philadelphia has rejected Johnson & Johnson's bid to dismiss class action lawsuits by retailers and insurers claiming the drugmaker conducted an anticompetitive scheme to shield its blockbuster rheumatoid arthritis drug Remicade from competition.

Former Insys sales director seeks separate opioid bribe trial

Dec 07 2018

A former regional sales director at Insys Therapeutics Inc charged with five other former executives and managers with conspiring to bribe doctors to prescribe an addictive opioid, and set to be tried with them in January, is seeking a separate trial.

World News

Canada warns U.S. not to politicize extradition cases

Canadian Foreign Minister Chrystia Freeland on Wednesday warned the United States not to politicize extradition cases, a day after President Donald Trump said he could intervene in the affair of a Chinese executive detained in Canada at Washington's request.